Zhejiang Cheng Yi Pharmaceutical Co., Ltd. (SHA:603811)

China flag China · Delayed Price · Currency is CNY
7.60
+0.06 (0.80%)
Jul 3, 2026, 3:00 PM CST
Market Cap3.38B +11.0%
Revenue (ttm)827.75M +10.8%
Net Income193.61M -9.4%
EPS0.44 -6.1%
Shares Out 444.76M
PE Ratio17.43
Forward PEn/a
Dividend0.21 (2.82%)
Ex-Dividend DateJun 26, 2026
Volume7,486,420
Open7.67
Previous Close7.54
Day's Range7.46 - 7.74
52-Week Range7.11 - 12.12
Beta0.12
Analystsn/a
Price Targetn/a
Earnings DateAug 27, 2026

About SHA:603811

Zhejiang Cheng Yi Pharmaceutical Co., Ltd. produces and sells APIs, injections, food, capsules, tablets, traditional Chinese medicines, preparations, pharmaceutical intermediates in China and internationally. The company was formerly known as Wenzhou No. 3 Pharmaceutical Factory and changed its name to Zhejiang Cheng Yi Pharmaceutical Co., Ltd. in April 2001. Zhejiang Cheng Yi Pharmaceutical Co., Ltd. was founded in 1966 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 1966
Employees 604
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603811
Full Company Profile

Financial Performance

In 2025, SHA:603811's revenue was 812.35 million, an increase of 13.72% compared to the previous year's 714.37 million. Earnings were 195.12 million, a decrease of -2.78%.

Financial Statements